1.
Girgis I, Chimalakonda A, Jones III J, Dockens R, Marchisin D, Darbenzio R, Singhal S, Throup J, Banerjee S. Lack of ECG effects of BMS-986165, an oral, selective tyrosine kinase 2 (TYK2) inhibitor: results from a thorough QT study in healthy subjects. J of Skin [Internet]. 2019Nov.9 [cited 2024Jul.23];3:S13. Available from: https://jofskin.org/index.php/skin/article/view/740